FindTrial
Sign In

No aspirin

DRUG5 trials

Sponsors

Kumamoto University, Liverpool Heart and Chest Hospital NHS Foundation Trust, Kyoto University, Graduate School of Medicine, Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA), Takeshi Morimoto

Conditions

Acute Coronary SyndromeArteriosclerosisAspirinCoronary Artery DiseaseCoronary DiseaseDiabetes Mellitus, Type 2Ischemic Heart DiseaseNon ST Segment Elevation Acute Coronary Syndrome

Phase 3

The Effect Of Aspirin On Survival in Lung Cancer
WithdrawnNCT01058902
Liverpool Heart and Chest Hospital NHS Foundation TrustAspirin, Non Small Cell Lung Cancer, Survival
Start: 2010-08-31End: 2020-08-31Updated: 2016-03-07

Phase 4

Japanese Primary Prevention of Atherosclerosis With Aspirin for Diabetes (JPAD) Trial
CompletedNCT00110448
Kumamoto UniversityArteriosclerosis, Coronary Disease, Diabetes Mellitus, Type 2
Start: 2002-12-31End: 2008-04-30Updated: 2016-11-02
ShorT and OPtimal Duration of Dual AntiPlatelet Therapy-3 Study
Active, not recruitingNCT04609111
Kyoto University, Graduate School of MedicineAcute Coronary Syndrome
Start: 2021-01-29End: 2025-12-31Updated: 2024-06-14
Less Bleeding by Omitting Aspirin in Non-ST-segment Elevation Acute Coronary Syndrome Patients
NCT05125276
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)Non ST Segment Elevation Acute Coronary Syndrome
Start: 2022-05-13End: 2025-07-31Target: 3090Updated: 2023-07-19
Efficacy and Safety of Aspirin in Patients With Chronic Coronary Syndromes Without Revascularization
RecruitingNCT05347069
Takeshi MorimotoCoronary Artery Disease, Ischemic Heart Disease, Stable Angina Pectoris
Start: 2022-06-14End: 2030-12-31Target: 2890Updated: 2025-03-11

Related Papers

Effect of Proton Pump Inhibitors in Patients Undergoing Percutaneous Coronary Intervention With Aspirin-Free Strategy.
2025-11-13
Aspirin Versus Clopidogrel Beyond 1 Month After PCI in Patients With Oral Anticoagulation
Circulation Cardiovascular Interventions2025-09-242 citations
Aspirin vs Clopidogrel 1 Month After Acute Coronary Syndrome With High-Bleeding Risk or ST-Segment Elevation.
2025-06-041 citations
Aspirin-Free Strategy for PCI in Patients With High Bleeding Risk With or Without Acute Coronary Syndrome: A Subgroup Analysis From the STOPDAPT-3 Trial
Circulation Cardiovascular Interventions2025-05-143 citations
Aspirin vs. clopidogrel monotherapy beyond 1 month after complex percutaneous coronary intervention: a pre-specified subgroup analysis of the STOPDAPT-3 trial
European Heart Journal - Cardiovascular Pharmacotherapy2025-01-25
Aspirin vs. clopidogrel monotherapy after percutaneous coronary intervention: 1-year follow-up of the STOPDAPT-3 trial
European Heart Journal2024-08-3127 citations
Post-procedural Anticoagulation With Unfractionated Heparin in Acute Coronary Syndrome: Insight from the STOPDAPT-3 Trial.
2024-07-062 citations
An Aspirin-Free Strategy for Immediate Treatment Following Complex Percutaneous Coronary Intervention.
2024-05-015 citations
An Aspirin-Free Versus Dual Antiplatelet Strategy for Coronary Stenting: STOPDAPT-3 Randomized Trial
Circulation2023-11-23120 citations
Incidence of atrial fibrillation in elderly patients with type 2 diabetes mellitus
BMJ Open Diabetes Research & Care2022-03-016 citations
Low-Dose Aspirin for Primary Prevention of Cardiovascular Events in Patients With Type 2 Diabetes Mellitus
Circulation2016-11-16136 citations
How many unpublished studies? ClinicalTrials.gov (n = 2614 studies): diabetes | Closed Studies | Interventional Studies | Phase 3, 4 | Search Date: Oct 27, 2014
Figshare2014-01-01
Low-dose aspirin for primary prevention of atherosclerotic events in patients with type 2 diabetes: a randomized controlled trial.
2008-11-09523 citations